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1. Introduction 
For many drugs and xenobiotics glucuronidation is the major metabolic pathway of 
detoxification. There, a highly hydrophilic glucuronic acid is coupled to aliphatic / aromatic 
alcohols, thiols or carboxylic acids or even amines. Although the glucuronidation is usually 
considered a deactivation reaction, electrophilic acyl-glucuronides can be formed from a 
number of acidic drugs, such as diclofenac, zomepirac, diflunisal, valproate, ibuprofen, 
gemfibrozil and clofibrate, among others. Acyl-glucuronides have been linked with 
idiosyncratic adverse drug reactions due to the chemical reactivity towards plasma and 
tissue proteins and nucleic acids (Shipkova, Armstrong et al. 2003). Even the most common 
ether O-glucuronides, which are generally pharmacologically inactive, can be cleaved back 
to the active parent compounds inside the human body or in the in the environment. 
Similarly, some N-glucuronides have been linked to bladder cancer due to their fast 
deconjugation which releases the toxic aglycone inside the bladder. Therefore, on many 
occasions in drug metabolism studies or in toxicology, it is necessary or prudent to detect 
and to quantify glucuronide metabolites in biological samples.  
2. Overview of glucuronide quantification approaches 
In the past, the majority of the quantification methods for glucuronides involved an 
enzymatic (-glucuronidase) or an acid/base hydrolysis of the glucuronide ether bond prior 
to HPLC analysis, mainly because the hydrophilic glucuronides were difficult to separate 
from the interfering matrix components (Kadi and Hefnawy 2009). Nowadays, the highly 
selective and sensitive triple quadrupole LC-MS/MS instruments enable us to directly 
measure the glucuronides without the need to de-conjugate the glucuronide moiety before 
the analysis. This offers some significant benefits: quicker sample preparation and better 
accuracy and precision, as the glucuronide hydrolysis  may be incomplete or the aglycon is 
unstable in hydrolytic conditions or binds non-specifically to the -glucuronidase or matrix 
components (Kadi and Hefnawy 2009). Furthermore, the glucuronide moiety can be bound 
to different nucleophilic functional groups on the parent aglycone, giving rise to different 
glucuronide structural isomers, which can then be selectively quantified.  Differentiation 
among glucuronide isomers might be important as they can have profoundly different 
pharmacological activity, for example the morphine-6-glucuronide has a many times greater 
affinity towards the -opioid receptor than the morphine-3-glucuronide or the morphine-
6,3-diglucuronide (Loser, Meyer et al. 1996). 
www.intechopen.com
 
Tandem Mass Spectrometry – Applications and Principles 
 
532 
On the other hand, a direct measurement of the glucuronides in biological samples requires 
the use of their authentic analytical standards for the preparation of the calibration and the 
quality control samples in an appropriate matrix. Quite often, these analytical standards are 
not easily obtainable and even if they are commercially available, a few milligrams may cost 
up to several thousand of US Dollars or even more. Their isotope labeled analogs (for use as 
internal standards) can cost even more. To overcome this difficulty, several possibilities exist 
(Soars, Mattiuz et al. 2002; Sanceau, Larouche et al. 2007). The first is a chemical synthesis of 
the glucuronide standards, which can be performed either by a glucopyranoside synthesis 
or by the use of glucuronide donors or glucuronide precursors and often involves a several 
step reaction, which is time-consuming and the glucuronide yield is often very low (Yu, Zhu 
et al. 2000; Burkon and Somoza 2008). The second approach is an enzymatic synthesis of the 
glucuronides, where the aglycone is incubated with uridine diphosphoglucuronosyl 
transferases (UGTs) in the presence of a co-factor uridine-diphospho-glucuronic acid 
(UDPGA). Recombinant human UGTs or human microsomes can be used in these 
incubations in order to obtain the same glucuronide isomers as present in human body 
fluids (Trontelj, Bogataj et al. 2007). Some alternative methods to microsome incubations 
have also been described where the UGT enzymes are adsorbed or covalently linked onto 
silica or to a monolithic carrier surface. There, the enzymes can be re-used many times or 
can continuously catalyze the glucuronidation reaction by a substrate flow-through 
technique called immobilized enzyme reactors (IMER) (Kim and Wainer 2005). 
The third approach is a bioproduction process, where specially modified strains of bacteria 
(for example Streptomyces sp.) can be used to produce large amounts of certain glucuronides 
(Trdan, Roskar et al. 2011). However, the latter approach needs an extensive clean-up and 
purification procedures in order to obtain high purity analytical standards (Briggs, Baker et 
al. 1999). The fourth approach is the semi-quantitative method where one aliquot of the 
sample containing the glucuronides is subjected to a quantitative beta-glucuronidase 
cleavage and the other aliquot is not. After the analysis of first and second aliquot, the 
glucuronide response factor is calculated as the ratio between the glucuronide signal from the 
second aliquot and the rise of the signal of aglycon in the first aliquot (originating from the 
cleaved glucuronide). Then, in subsequent analyses, the glucuronide response factor is used 
to quantify the glucuronides without the -glucuronidase treatment and by using the 
calibration curve of the easily obtainable aglycone (Sanceau, Larouche et al. 2007; Farrell, 
Poquet et al. 2011; Trdan, Roskar et al. 2011). In such scenarios, a careful study of the 
possible relative matrix effects on glucuronides is warranted. The semi-quantitative 
approach can also be used if a radiolabeled parent is available by correlating the radioactive 
responses from the radiolabeled metabolite and parent to the corresponding LC-MS/MS 
responses (Yu, Chen et al. 2007). If a radiolabeled parent is not available, the labeled 
glucuronide can be synthesized by microsomes using a radiolabeled UDP-glucuronic acid 
(UDP-[U-14C]-GlcA) (Maurel 2010). The semi-quantitative approach is based on the 
assumption that the concentration-response relationship for glucuronide is linear. However, 
on many occasions in LC-MS analyses, this is not the case. Therefore, it is advisable to check 
the response factors across the expected glucuronide concentration range (Trdan, Roskar et 
al. 2011) . 
3. Sample preparation techniques 
This step is often the most crucial in the whole analysis. The choice of the sample 
preparation method is based on the glucuronide concentration, the available sample 
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volume, the matrix type and the analyte stability. In this section, the most commonly used 
methods for sample preparation are presented, including: deconjugation with -
glucuronidase, solid and liquid extractions, protein precipitation, on-line SPE and others.  In 
order to ensure adequate stability of the glucuronides prone to hydrolysis or acyl-group 
migration, a proper sample collection / storage / buffering is required. Therefore, the 
stability considerations are discussed as well.  
3.1 Deconjugation with -glucuronidase 
This is not a complete sample preparation procedure; it is just one of the optional steps 
within the sample handling workflow which is used to liberate the aglycone from 
glucuronide in order to quantify it more easily. Historically, the -glucuronidase treatment 
was the most commonly used approach to quantify glucuronides of xenobiotics in biological 
samples (Kadi and Hefnawy 2009). However, this procedure has some drawbacks and 
considerations that have to be taken into account.  
First, not all glucuronides can be cleaved by the commercially available enzymes, such as 
the -glucuronidase from E. coli or Helix pomatia, bovine liver glucuronidase etc. Some N-
glucuronides may remain quite stable in such incubation mixtures and require a chemical 
cleavage with, for example, hydrazine hydrate (Frandsen 2007) or a hydrolysis with a dilute 
acid. On the other hand, the acyl (ester) glucuronides can be easily cleaved by a dilute base 
(0.1-1.0 M NaOH) with mild heating (Wen, Stern et al. 2006; Zhang, Zhu et al. 2008). -
glucuronidases isolated from different species may have different enzyme activities toward 
various substrates and even for structural isomers of glucuronides (Choi, Ha et al. 2010). In 
addition, some acyl-glucuronides or their isomers formed after acyl-migration can be -
glucuronidase stable and require a basic hydrolysis (with 1M NaOH) (Wen, Stern et al. 
2006). Furthermore, -glucuronidases isolated from mollusks (like Helix pomatia or Patella 
vulgata) may posses a significant sulfatase activity as well. Note that molluskan -
glucuronidases may be less effective in hydrolyzing ether glucuronides than E. coli -
glucuronidases (Smith and Athanaselis 2005). 
Secondly, in most cases, there is at least some amount of aglycone present in the starting 
material. Therefore, the measured aglycone concentration after deconjugation has to be 
subtracted by the initial aglycone concentration in order to quantify the amount of present 
glucuronide. Of course, in such calculations, it is necessary to use the molar concentrations 
and not mass/volume concentrations because the molecular mass of the freed aglycone is 
lower by 176 amu compared to the mono glucuronide in positive ESI, which corresponds to 
the loss of monodehydrated glucuronic acid.  
Thirdly, the binding of glucuronides to the matrix components can significantly reduce the 
-glucuronidase cleavage efficiency. For example, a complete cleavage of raloxifene 
glucuronides dissolved in aqueous solution of acetate buffer takes only a few minutes if not 
seconds, but if plasma proteins are present, the glucuronides can be >95% bound, and 
consequently, it can take up to even 24-48 hours to completely deconjugate the same amount 
of glucuronides (author’s own experience, data not published). Similarly, when performing a 
glucuronide quantification in tissue samples, the -glucuronidase may not have a complete 
access to all subcellular compartments, such as microsomes, resulting in an underestimation 
of glucuronides. In such instances, better results may be obtained after an acid hydrolysis 
(Gu, Laly et al. 2005). Additionally, some -glucuronidases may posses other catalytic 
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properties as well, like for example steroid conversion with preparations from H. pomatia 
(Gomes, Meredith et al. 2009). 
Alternatively, instead of deconjugation with beta glucuronidases, also a methanolysis of 
glucuronides can be used, which frees both glucuronide and sulfate conjugates. The 
downsides of this approach are an increase in baseline noise in mass spectrometer and a 
poor efficiency of deconjugation (Cooper, Currie et al. 2001; Yu, Ho et al. 2005). 
Therefore, if the -glucuronidase treatment turns out to be effective on the studied 
glucuronide within its sample matrix, then this should be the method of choice for its 
deconjugation. The most common procedure for a -glucuronidase treatment is as follows. 
3.1.1 Sample pre-treatment 
Biological samples, such as urine, plasma or feces are simply diluted in 1:1 
(volume/volume) ratio with purified water or buffer. Note that the buffer can be added 
later on as well. A feces sample has to be homogenized prior to the dilution step. If an 
internal standard is to be used, this is the correct moment for its addition. However, in some 
instances, for example, if a deuterated glucuronide internal standard is not available and 
another glucuronide or a structural isomer or a compound with similar retention factor is 
used instead, then it may be beneficial to add the internal standard solution after the 
extraction procedure in order to minimize the IS content variability. In such cases, the aim of 
internal standard addition is not to correct for the sample preparation inconsistencies, but 
rather to correct the possible matrix effects. Furthermore, if an internal standard is not a 
deuterated or a C-14 labeled analogue, then it may as well be extracted differently than the 
analyte, thereby increasing the method variation (RSD). Rarely, the samples are extracted or 
treated with an organic solvent prior to the -glucuronidase treatment. This shortens the 
cleavage incubation time as the protein binding is usually eliminated by the extraction with 
an organic solvent. However, the organic solvent must be evaporated before the enzyme is 
added to the sample.  
3.1.2 Sample buffering  
The pH of incubation buffer may be important for the reaction velocity and the selectivity 
towards the glucuronides or the sulfates. Quite high buffer concentrations can be used (0.1-
1.0 M). The optimal pH range depends on the enzyme source. If molluskan -glucuronidase 
is used, then the pH should be 4.0 - 4.5 for maximal glucuronidase activity. However, if 
maximal sulfatase activity is desired, then the pH should be 6.5 (Tephly, Green et al. 1997). If 
bovine liver glucuronidase is used, then the maximal glucuronidase and sulfatase activity is 
achieved at pH 4.4 (Himeno, Hashiguchi et al. 1974). If E. coli glucuronidase is used, then 
there should be no sulfatase activity and the maximal velocity is achieved at pH range of 6-7 
(DongHyun, YoungHo et al. 1995). The selection of buffer salts depends on the desired pH 
range. For acidic buffers, acetate buffer is most commonly used, for more neutral pH values, 
phosphate or carbonate buffers can be used. 
3.1.3 Sample incubation  
The sample incubations are usually performed in at least two parallels. Sometimes, a 
separate incubation of a commercially obtainable substrate (for example 4-
methylumbelliferone glucuronide) in the same matrix is used to monitor the -
glucuronidase activity (Blount, Milgram et al. 2000).  Each incubation should contain 200 - 
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25 000 units of -glucuronidase per 1 mL of incubation medium (Gu, Laly et al. 2005; 
Belanger, Caron et al. 2009). Note that vendors define the glucuronidase activity in Roy or in 
Fishman units, where 1 Fishman unit releases 1 µg phenolphthalein from phenolphthalein-
β-glucuronide in 1 h at 38°C. Typically, the incubations are left in a thermostated shaker for 
1-5 hours at 37-60°C. For slow deconjugation reactions, 24 hours and longer incubations are 
needed in order to quantitatively deconjugate all the present glucuronides. It is noteworthy, 
that an excess of enzyme may lead to incomplete deconjugation, therefore it is important to 
determine the appropriate incubation conditions for the specified conjugate in a given 
sample matrix (Gomes, Meredith et al. 2009). 
3.1.4 Reaction termination and final sample preparation  
Prior to the analysis, the proteins have to be denatured and removed. This is usually 
accomplished by a subsequent liquid-liquid extraction with an organic solvent like ethyl 
acetate, cyclohexane, diethyl ether, methyl tert-butyl ether. Note that if the extraction 
solvent is highly non-polar, like cyclohexane alone, then it may fail to extract the possibly 
remaining hydrophilic glucuronide from the sample, resulting in an unnoticed glucuronide 
left-over and consequently its under prediction.  Therefore, a combination of organic 
solvents can be used, like for example, ethyl acetate/diethyl ether (1:1, vol/vol), in order to 
extract both, aglycone and glucuronide.  Alternatively, a solid phase extraction can be used 
(Weinmann, Vogt et al. 2000; Stolker, Niesing et al. 2004). After the protein removal, a pH re-
adjustment may be necessary in order to gain an acceptable recovery, especially for basic 
aglycones, which tend to be protonated at acidic pHs of -glucuronidase incubations. After 
evaporating the organic solvent, the samples are reconstituted in a solvent similar to mobile 
phase and injected into LC-MS/MS. Alternatively, instead of a liquid-liquid extraction, it is 
also possible to denature the proteins with an equal volume of ice-cold acetonitrile, or by 
adding approximately 1/10 of incubation volume of trichloroacetic acid solution (TCA) 
(10% vol/vol) (Lu, Palmer et al. 2003), followed by a brief vortex mixing, centrifugation (15 
min at 3 000 – 15 000  g) and injection of the supernatant into LC-MS/MS.  Such sample 
preparations procedures, without an extraction, allow a confident detection of the possibly 
still remaining glucuronides; however, the analyte responses may be lower due to the 
sample dilution and the peak broadening, in contrast to the liquid-liquid and solid phase 
extractions, where the analytes can be concentrated many times and reconstituted in a 
weaker elution solvent.  
3.2 Liquid-liquid extraction  
Sometimes, a liquid-liquid extraction (LLE) may be preferable over a solid phase extraction 
(see paragraph 3.3) because of its greater simplicity and applicability to almost all 
laboratories and low cost (Jemal, Ouyang et al. 2010).  However, the extraction of 
glucuronides into a lipophilic organic solvent can be difficult because of the glucuronide’s 
highly polar and hydrophilic nature (both the glucuronic acid and hydroxyl groups can be 
ionized). In order to de-ionize the glucuronic acid moiety, acidic conditions should be 
ensured during the extraction. For example, if 1 mL urine sample is to be extracted, then 
some 200 µL of 1 M HCl should be used to sufficiently protonate the glucuronic acid (pKa 
3.1-3.2) (Paradkar 2008). Note that if extraction of both glucuronide and aglycone is 
required, then acidic extraction conditions may diminish the extraction efficiency of the 
basic aglycones. The extraction efficiency for both types of analytes may be improved if a 
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combination of organic solvents is used (see subheading 3.1.4 for details and references). 
The choice of the extraction solvents may have a strong impact on the matrix effects later in 
LC-MS analysis. Methyl-tert-butyl ether (MTBE) and n-butyl chloride seem to extract only 
negligible amounts of lyso-phosphatidyl choline, which is the matrix component that elutes 
early from a reverse phase (RP) column and tends to interfere with ionization of drugs and 
their metabolites (Jemal, Ouyang et al. 2010).  However, both solvents are highly non-polar 
and the recovery of glucuronides is expected to be low. Nevertheless, if aglycone should be 
extracted after a -glucuronidase treatment, then these two solvents can be used 
successfully for that purpose. 
3.3 Solid Phase Extraction (SPE) 
SPE has become a very popular sample preparation technique in bioanalysis due to low 
sample volume requirements, low organic solvents consumption, high recovery, good 
reproducibility, easy automation, high speed and high throughput. There are also some 
drawbacks, like a possible low recovery of hydrophilic analytes (some glucuronides 
included), column blockage due to sample viscosity or precipitation, analyte instability in 
elution solvent, and lot-lot variability in column packaging (Telepchak, August et al. 2010).  
The principle mechanism of separation in a SPE is similar to analytical chromatography, i.e. 
the analytes in sample solution bind with a greater affinity to the solid surface than the 
matrix components which are washed away. Afterwards, a stronger elution solvent is used 
to elute the analytes from the solid surface and collect them for further analysis (HPLC, LC-
MS/MS). 
The main goal while developing a SPE method is to achieve the highest possible 
reproducibility, good matrix clean-up and a high recovery, if possible. The retention of 
glucuronides on a solid phase sorbent can be facilitated by a number of mechanisms, from 
hydrophobic to ion-pairing. The chemistry and hydro-lipophilic properties of the aglycone 
play a major role. There are a number of possible combinations of solid phases / eluents and 
the analyst should choose the right combination that gives the best performance for the 
samples to be analyzed. A good starting point is the sorbent selection kit or the method 
development kit, which is offered by the majority of leading SPE cartridge producers (like 
Phenomenex, Waters, Agilent, Varian, Supelco, Macherey-Nagel, Thermo, etc.). Usually, in 
such a package, there are at least four different cartridge chemistries: strong cation 
exchange, a weak cation exchange, a strong anion exchange and a weak anion exchange. 
There are also classical reversed phases available, like C-18, C-8, C-4 and polymeric phases 
for example divinylbenzene and N-vinylpyrrolidone. A mixed-mode SPE of glucuronides is 
also possible, where an ionized analyte binds to an ion-exchange sorbent due to its charged 
state whereas neutrals can be retained at the same time due to their lipophilic interactions 
with the polymeric or reversed phase part of the sorbent. The manufacturers also propose 
the generic condition/wash/elution solvent protocols. After subjecting the pre-spiked, post-
spiked, and solvent-only samples to various sorbents (in replicates), the subsequent LC-
MS/MS analysis shows which sorbent chemistry gives the highest and the most 
reproducible recovery (RE) and can also show the matrix effects (ME). See the paragraph 5.5. 
In glucuronide extraction with SPE, special attention should be paid to the washing step if 
the analytes are retained by a reverse phase mechanism. Too high percentage of organic 
solvent can easily wash the hydrophilic glucuronides into waste (author’s own experience, 
data not published). If silica based or polymeric reversed phase cartridges are used, 
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decreasing the methanol content in the elution solvent can reduce the elution of 
phospholipids which can cause unwanted matrix effects later in LC-MS. On the other hand, 
100% acetonitrile as an elution solvent drastically minimized the phospholipid elution on 
silica based cartridges (Lahaie, Mess et al. 2010).  If endogenous glucuronides are present in 
“blank” samples , like for instance steroid glucuronides, then it is necessary to spike the 
blanks with labeled glucuronides for matrix effect and recovery calculation (Pozo, Van 
Eenoo et al. 2008).  The glucuronides can be retained to various extents on a reversed phase 
(Trontelj, Bogataj et al. 2007), on a strong anion-exchange (Pu, McKinney et al. 2004), on a 
mixed-mode (Kakimoto, Toriba et al. 2008) and even on strong and weak cation exchange 
sorbents (Okura, Komiyama et al. 2007), depending on the ionization and lipophilic 
properties of the aglycone. Even highly polar glucuronides and sulfates, like paracetamol 
conjugates can have a high recovery on mixed-mode weak anion exchange sorbents like 
Waters Oasis WAX (Sunkara and Wells 2010). Some lipophilic conjugates, like steroid 
glucuronides and sulfates may not be eluted fully with only methanol and may require 
addition of ion-pairing reagents like 5 mM triethylamine (Isobe, Serizawa et al. 2006). It is 
noteworthy that the ion-exchange or mixed mode SPE is preferred over the reversed phase 
mechanism of retention since the former two methods can include a rigorous washing of the 
cartridge with a strong solvent, for example 100% methanol  or ethyl acetate, without any 
detrimental effect on the analyte recovery while producing the lowest possible matrix effects 
(Chambers, Wagrowski-Diehl et al. 2007). With the mixed mode anion-exchange SPE 
sorbents it is even possible to separate not only the conjugates from the parent compounds, 
but also to differentiate between the various types of conjugates, like glucuronides from 
sulfates (Fontanals, Marcé et al. 2010).  
3.4 Protein precipitation  
Protein presence in the samples can cause significant problems in glucuronide analysis. 
First, the glucuronides can be more than 50% protein bound (Hochner-Celnikier 1999; 
Burkon and Somoza 2008) which may negatively impact the absolute method recovery. In 
high throughput analysis, there is a tendency to minimize the sample preparation steps. 
Protein precipitation (PP) is one of such fast and easy-to-automate procedures. Therefore, PP 
is quite a popular sample preparation technique, especially for plasma samples and in vitro 
incubations, where this step terminates the enzyme reactions as well (Rosenfeld 2004). 
However, samples obtained with a PP procedure may contain higher amounts of 
problematic matrix components than samples after a SPE or LLE. Furthermore, 
chromatography problems may arise, since the percentage of organic solvent in the sample 
is higher, worse peak shape can be expected, shorter column life-time, worse separation and 
lower responses due to the sample dilution with a precipitating agent. In addition, more 
frequent ESI spray chamber and capillary cleaning may be required (Bakhtiar and 
Majumdar ; Elbarbry and Shoker 2007), (author’s experience). Most importantly, worse 
matrix effects can be expected with PP than with either LLE or SPE. The PP is most 
commonly accomplished with an addition of an organic solvent in 3:1 volume ratio to the 
sample. The most commonly used organic solvents are acetonitrile or methanol, which 
should precipitate at least 99% of the proteins. Acidification of the samples is another 
effective alternative to the organic solvents; a 6:10 ratio of 10% TCA should precipitate more 
than 99% of the proteins, however the resulting drop in pH can cause analyte instability. A 
1:1 (vol/vol) addition of 2 M perchloric acid to a plasma sample precipitates the proteins but 
www.intechopen.com
 
Tandem Mass Spectrometry – Applications and Principles 
 
538 
may not release all of the protein bound glucuronides and may not ensure the stabilization 
of acyl-glucuronides despite the acidic pH. Better results have been obtained with an 
addition of 1:2 (vol/vol) 15% metaphosphoric acid to a plasma sample (de Loor, Naesens et 
al. 2008). Addition of metal ions (like zinc sulfate) or hydrophilic salts (like ammonium 
sulfate) is used less frequently to precipitate the proteins in LC-MS analyses (Rosenfeld 
2004). After the precipitation, a centrifugation is used to separate the liquid supernatant 
from the proteins. Centrifugal field of 15.000 × g for 10 minutes is usually enough for 
complete sedimentation. Supernatant can be directly injected or evaporated and then 
reconstituted.  
3.5 Hybrid SPE 
A novel sample clean-up procedure has been recently introduced, the Hybrid SPE, which 
should combine the advantages of both the protein precipitation and SPE. It is said to be 
quick, simple and should provide extracts almost free of phospholipids, one of the main 
culprits for matrix effects. The proteins in samples are precipitated with a triple volume of 
acetonitrile, then passed through the hybrid SPE cartridges, and directly injected into the 
LC-MS. The hybrid SPE cartridges should firmly bind phospholipids and eliminate them 
from the sample. Unfortunately, the glucuronides can bind to the same sorbent very 
efficiently; therefore the glucuronide recovery may be close to 0% (author’s own experience 
with haloperidol glucuronide, (Silvestro, Gheorghe et al. 2011)). Hence, this method may be 
used in applications, where a complete elimination of glucuronide is needed. 
3.6 Direct injection of biological samples  
The recent advances in increasing the sensitivity of triple quad mass spectrometers for 10 
times and more made it possible to directly inject some liquid biological samples (like for 
example urine or saliva) into LC-MS/MS systems almost without any sample pre-treatment. 
Actually, at least the particulates have to be removed from the samples somehow prior to 
their injection to prevent injector fluid path blockage, column deterioration and pressure 
build-up. Narrow bore UHPLC capillaries and columns are especially sensitive to 
particulate impurities because of their finer pore diameters and dense inlet filters.  
Therefore, at least some sort of sample pre-treatment is necessary, like diluting the samples 
1:10 with water in combination with filtering through 0.2 µm pore filters or centrifugation 
(McMaster 2007; Kaklamanos, Theodoridis et al. 2011).  Such an approach without any form 
of extraction greatly reduces the time needed for an analysis; however the method and 
system robustness parameters should be carefully monitored. Furthermore, the majority of 
biological samples may contain at least some amount of proteins, which may pass through 
the aforementioned filters and precipitate later on the column or in the tubing when the 
percentage of organic modifier increases. This difficulty can be overcome by two 
approaches. First, an on-line SPE can be used to wash the endogenous impurities from the 
sample into waste before they can reach and contaminate the analytical column and mass 
spectrometer (see subheading 3.6 (On line-SPE) for details). Second, the samples can be 
incubated with proteases in order to degrade the proteins into peptides which are no longer 
a threat to a LC-MS system (Yu, Ho et al. 2005). 
3.7 On-line SPE 
On-line SPE is a system which allows injecting crude samples or diluted samples onto an 
extraction column, which is first washed with a weak solvent to waste to remove the salts 
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and proteins and then eluted with a stronger solvent onto the analytical HPLC or UHPLC 
column. The key to this separation procedure is the turboflow chromatography. Sometimes, 
it is also designated as a size-exclusion chromatography or a restricted access material 
(RAM) or a high turbulence liquid chromatography (HTLC).  This process takes place in a 
short extraction column (for example 30x1, 25x4 mm) with RP silica or polymeric based 
stationary phase with large particles and pores (25-50 µm) for greater robustness (Bentayeb, 
Batlle et al. 2008). After the injection, the flow rate is quite high (1-5 mL/min), so the 
proteins and other macromolecules cannot enter the pores of the stationary phase and are 
quickly washed away into waste. Smaller molecules however can enter the pores and are 
therefore retained until a stronger solvent elutes them (usually in reverse flow direction) 
onto the analytical column. A dilution step in a high pressure mixing tee may be employed 
during the transfer of the analytes from the extraction onto the analytical column in order to 
concentrate the analytes in a narrow band on analytical column for narrower peak shape, 
resulting in better sensitivity (Ye, Kuklenyik et al. 2005). The hardware setup for such an on-
line SPE is usually a modified HPLC with a larger sample loop (injection volumes are 
usually 10-900 µL), an additional binary or quaternary pump, and an additional six- or ten-
port valve. If a 10-port valve is used, two extraction columns can be used at the same time to 
increase throughput; this allows a combination of sample loading, washing, equilibration 
and elution steps simultaneously (Ferreirós Bouzas, Dresen et al. 2009). Typically, on-line 
SPE columns can withstand a few hundred injections of diluted plasma or urine samples, it 
depends on the sample matrix and injection volume (Rosenfeld 2004). Care must be taken to 
disrupt the protein binding prior to the injection; otherwise the recovery may be 
diminished. Therefore, some authors use a protein precipitation step, followed by 
evaporation and reconstitution before the samples are injected into an on-line SPE (Ferreirós 
Bouzas, Dresen et al. 2009) 
3.8 Dried blood spots 
Dried blood spots (DBS) and dried plasma spots (DPS) are novel approaches for quantitative 
determination of analytes in systemic circulation. Very low sample volumes are needed (as 
low as 15 µL up to 100 µL) for a successful quantitative HPLC-MS/MS method (Spooner, 
Lad et al. 2009). Plasma or blood is applied onto a paper sorbent; after drying, a punch from 
DBS (or DPS) sample is extracted with a solvent, which is injected in HPLC-MS/MS. This 
method offers some significant benefits over the classical sample preparation techniques: 
very low volume of plasma or blood is needed, which minimizes the patient burden (finger 
prick or heel prick sampling instead of venous cannula) and is very appropriate for animal 
and pediatric studies; the stability/transport/storage of samples are a lot simpler because 
no refrigeration is needed and in case of DBS, also no centrifugation at the site of the clinical 
trial is required. Furthermore, when the stability of paracetamol glucuronide and sulfate 
was studied in DBS samples, no noticeable degradation and paracetamol formation was 
observed (Spooner, Lad et al. 2009). This technique can be automated for high throughput 
analysis in pharmaceutical drug discovery and clinical trials (Barfield and Wheller 2010). 
Apart from classical HPLC-ESI-MS configuration, some direct DPS analysis tools have been 
introduced, such as the thin layer chromatography MS interface (CAMAG) which does not 
require punching of DPS samples (Abu-Rabie and Spooner 2009), direct elution or on-line 
desorption (Deglon, Thomas et al. 2009), desorption electrospray ionization (DESI) and 
direct analysis in real time (DART) (Takats, Wiseman et al. 2004). It should be emphasized 
however, that all the presented direct DPS analysis techniques without any 
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chromatographic separation are principally unsuitable for glucuronide analysis due to the 
possible in-source deconjugation of glucuronides or sulfates or even N-oxides back to their 
parent molecules and ion channel cross-talk (Wong, Pham et al. 2010). 
3.9 Glucuronide derivatization 
Some of the more hydrophilic glucuronide conjugates (like paracetamol-glucuronide) 
exhibit a poor ionization either due to their hard-to-ionize aglycones or due to the slow 
desolvation caused by the low percentage of organic solvent in mobile phase composition 
required for their chromatographic retention. In such instances, two approaches may be 
explored to overcome the low glucuronide signals. First, the hydrophilic interaction 
chromatography (HILIC) or a Hypercarb™ column may be a good option to increase the 
percentage of organic solvent for elution of glucuronides (see subheading 4.4). Secondly, 
after the extraction, the glucuronides can be derivatized at their carboxylic moiety using an 
ethereal diazomethane in methanol. Methyl esters are formed at room temperature. 
Afterwards, the samples are dried and reconstituted with methanol and injected into LC-
APCI-MS, where a positive or negative ionization mode can be used to detect either [M+H]+ 
or [M+O2]- ions, respectively  (Ohta, Kawakami et al. 2003). 
3.10 Glucuronide stability issues  
The stability of any type of glucuronide (O-, N-, S-, acyl-) should be thoroughly investigated 
at all stages of the analysis: sample acquisition and storage, during the sample preparation 
and after the sample preparation (autosampler time included).  It has to be emphasized that 
even if the glucuronides are quantified indirectly, with -glucuronidase treatment, the 
stability of glucuronides is crucial prior to this step, otherwise the glucuronides may be 
underestimated and the aglycone overestimated. The stability study is especially important 
for acyl- and N-glucuronides, which can be highly labile compounds in slightly alkaline and 
even neutral solutions (Mullangi, Bhamidipati et al. 2005).  Even acidic additives like 
perchloric acid may not provide a good-enough stabilization of the acyl-glucuronides. With 
acyl-glucuronides, either a hydrolysis or an acyl migration can occur. Acyl migration is a 
process, where the aglycone is being transferred from the C-1 on glucuronide ring to C-2, C-
3, C-4 carbon atoms. Such isomeric glucuronides become more stable towards -
glucuronidases and require alkaline conditions for their hydrolysis. Usually, the samples are 
acidified if acyl-glucuronides are present. Low temperature, such as 4°C may play a major 
role for acyl-glucuronide stability (Tan, Jin et al. 2009). Plasma and tissue samples may 
contain endogenous -glucuronidases which may compromise even O-glucuronide stability.  
4. Chromatographic methods 
It is imperative to achieve a good chromatographic separation of conjugates (glucuronides) 
not just from the solvent peak but also from their parent molecules, otherwise they can de-
conjugate in MS ion source (ESI, APCI) or in the collision cell (ion channel cross-talk), 
thereby increasing the signal of the parent, which may cause its false over-estimation  
(Naidong, Lee et al. 1999). This is why Jemal et al. suggest to use an incurred plasma sample 
(plasma after dose which still contains metabolites) during the method development in 
order to ascertain that the developed method for a drug is not compromised by their 
presence either by chromatographic co-elution and channel cross-talk or by deconjugation 
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during the sample handling (Jemal, Ouyang et al. 2010). The glucuronides often prove to be 
difficult analytes for HPLC separations. First, in most instances, they are rather hydrophilic, 
and therefore they tend to elute near the peak of the solvent or the hydrophilic matrix 
components. At the same time, the strongest ion suppression is often observed at the 
beginning of the chromatographic run. Secondly, if more than one glucuronide structural 
isomers are present in a sample, i.e. the glucuronide acid moiety can be bound to different 
nucleophilic centers on the aglycon, then the chromatographic separation may be difficult 
and requires a careful gradient elution (Trontelj, Bogataj et al. 2007; Trdan, Roskar et al. 
2011). Furthermore, the chromatographic separation of glucuronide structural isomers is 
crucial, as they share the same parent mass to charge ratio and the fragmentation pattern; 
therefore a tandem mass analyzer cannot distinguish among the different co-eluting 
isomers. Ultra high pressure liquid chromatography (UHPLC) seems to offer some 
significant advantages over the classical HPLC in terms of higher selectivity towards the 
glucuronide isomers, a greater sensitivity and a higher speed of analysis (Korfmacher 2009). 
4.1 Reversed phase chromatography 
Reversed phase HPLC and UHPLC on C-18 columns has been used quite successfully for 
glucuronide separation (Kemp, Fan et al. 2002; Trontelj, Bogataj et al. 2007; Trdan, Roskar et 
al. 2011). The mobile phase is usually neutral to slightly acidic (pH 2.5-6) and the buffers 
used are 0.01 – 0.1% formic or acetic acid. 2-5 mM ammonium acetate with or without acetic 
acid addition may also be used. The organic phase is usually acetonitrile because in 
comparison to methanol, acetonitrile may provide a better peak shape of basic compounds 
and glucuronides, a better resolution among the structural glucuronide isomers and a 
higher MS response (author’s own experience). Usually, a gradient is started at a very low 
percentage of organic modifier (2-10%) in order to assure an adequate retention of the 
glucuronides and a good separation from the hydrophilic matrix components  (Kemp, Fan et 
al. 2002; Fayet, Béguin et al. 2009). Ballistic gradients are not optimal for glucuronide HPLC 
methods if the samples may also contain the parent molecule or glucuronide isomers. Ion 
channel cross-talk and in-source deconjugation, can both cause inaccuracy in quantification 
of the parent if it is not adequately separated from conjugates (Mei and Morrison 2009). 
Furthermore, greater matrix effects may also be observed in fast or ballistic gradients due to 
the poorer separation of analytes from the matrix components  (Chambers, Wagrowski-
Diehl et al. 2007). A more efficient chromatographic separation of analytes from the 
endogenous or other interfering components, such as drug vehicles, PPG, PEG or even over-
the-counter medicines like analgesics, may be achieved with UHPLC columns resulting in 
lesser matrix effects (Marín, Gracia-Lor et al. 2009). 
4.2 Ion-pairing reagents 
Although ion-pairing reagents have proven to be beneficial for glucuronide retention (Yau, 
Vathsala et al. 2004), such techniques have rarely been used in LC-MS analyses due to the 
limited compatibility of ion-pairing reagents with ionization and desolvatation in LC-MS 
interface. A successful and robust application of hexylamine as an ion pairing reagent 
together with a careful control of mobile phase pH has been described for acidic metabolites 
retention and detection with LC-negative-ESI-MS. In this case, no interference was observed 
from hexylamine as it is a volatile reagent and ionizes only in the positive mode (Coulier, 
Bas et al. 2006). With a similar ion pairing reagent, dimethylhexylamine, a switch from the 
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negative to the positive ESI is possible, which increases the sensitivity and selectivity of the 
method (Pruvost, Théodoro et al. 2008). Interestingly, even the addition of ion-pairing 
reagents just to the sample solution or to a reconstitution solvent (and not to the mobile 
phase) may significantly affect the retention of polar analytes. For example, a retention time 
of methadone has been doubled when the heptafluorobutanoic acid (HFBA) had been 
added to the reconstitution solvent after the extraction. Moreover, the addition of this ion-
pairing reagent significantly reduced the carry-over, probably because it reduced the 
attachment of the analyte to LC surfaces (Gao, Bhoopathy et al. 2006). 
4.3 Other reversed stationary phases 
Apart from the classic RP stationary phases, like the C-18 or C-8, phenyl group containing 
sorbents can be used in order to enhance the retention of mainly aromatic analytes through 
the formation of PI-PI bonds in addition to the regular mechanisms of RP chromatography 
(adsorption, partition, lipo- and solvophilic interactions) (Rafferty, Zhang et al. 2007). 
Additional selectivity enhancement may be observed when the percentage of methanol is 
increased in the organic modifier phase (in combination with acetonitrile), since the 
methanol can increase the formation of the aforementioned PI-PI interactions. Therefore, 
phenyl phases, such as the phenyl-hexyl, phenyl-butyl, biphenyl, pentafluorophenyl can be 
used to effectively increase the retention of hydrophilic aromatic metabolites, like for 
example paracetamol-glucuronide and sulfate (Xiong, Jin et al. 2010), or cyanidine-
glucuside-glucuronides (Marczylo, Cooke et al. 2009). Phenyl columns have been 
successfully used for more lipophilic metabolites as well, like for example cannabinoid 
glucuronides (Mazur, Lichti et al. 2009). 
4.4 Zwitter ionic and hydrophilic interaction chromatography (HILIC) 
HILIC is a mode of separation similar to the normal phase chromatography, but it can be 
performed on an ordinary RP HPLC instrument using a HILIC column and a mobile phase 
similar to the RP chromatography. In HILIC, the stationary phase is polar and the mobile 
phase is an aqueous/polar organic solvent, where water (or buffer) plays the role of a 
stronger eluting solvent. The order of peaks eluting from a HILIC column is reverse 
compared to RP chromatography, and glucuronides elute after their aglycones. Therefore, 
HILIC can be used primarily for the increased retention and separation of highly polar 
analytes. For example, a successful application of HILIC mechanism for morphine 
glucuronides separation and ionization has been described more than a decade ago 
(Naidong, Lee et al. 1999). The retention mechanism in underivatized silica is not only 
hydrophilic, but also hydrophobic and ion-exchange, which may cause a mixed-mode 
retention, and is sometimes difficult to predict (Nguyen and Schug 2008). In derivatized 
silica with a zwitterionic bonded phase (commercially known as ZIC-HILIC), there is no 
ion-exchange mechanism of retention (the zwitterions in stationary phase cancel each other 
out and there is no net charge of ion-exchange (Ahuja and Dong 2005)). For some phase I 
metabolites and parent compounds that are highly hydrophobic or less polar than 
glucuronides, the HILIC column may not provide enough retention and these compounds 
may be eluted close to the solvent peak. To overcome this issue, a dual column orthogonal 
approach has been described by (Qin, Zhao et al. 2008), where the estrogens have been 
derivatized with dansyl chloride (for better ionization) and separated on a RP column, while 
the polar estrogen conjugates were separated on a ZIC-HILIC column. In step one, the 
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sample is divided into two fractions: polar and non-polar: first, both columns are in series, 
and a sample is injected onto a RP column; the minimally retained polar conjugates are 
eluted from a RP column onto a HILIC column for subsequent separation in the next step, 
while the non-polar derivatized estrogens remain parked on the RP column. In step two, the 
mobile phase flows only through the HILIC column, where the polar analytes are separated 
and eluted to MS. In step three, the flow is directed only through the RP column, where the 
non-polars are separated and eluted to MS. This 2D orthogonal approach combines the 
benefits of both RP and HILIC methods and provides an excellent sensitivity (Thomas, 
Déglon et al. 2010). 
5. Mass spectrometry 
Glucuronides can be analyzed by LC-MS/MS in a number of different MS fragmentation 
experiments. The analyst will choose an appropriate MS experiment based on the purpose 
of the study. 
5.1 Ionization of glucuronides 
Before an analyte can enter a mass spectrometer and produce a signal, it must be efficiently 
ionized first. The majority of documented methods for glucuronide LC-MS detection 
employ the electrospray ionization (ESI) as it is the softest and the most suitable method for 
ionization without the in-source fragmentation of the relatively weak glucuronide ether or 
ester bonds (Kadi and Hefnawy 2009). On the other hand, sometimes it is desired to achieve 
an in-source fragmentation in order to record just one Selected Reaction Monitoring (SRM) 
trace for the glucuronide and the parent to achieve a better sensitivity (Felli, Martello et al. 
2011), (Schwartz, Desai et al. 2006). Of course, in such cases it is imperative to achieve a 
good chromatographic separation from the parent. The conjugate metabolites (glucuronides 
included) are usually ionized in positive ionization with electrospray (+ESI) (Keski-Hynnilä, 
Kurkela et al. 2002; Levsen, Schiebel et al. 2005). Generally, the glucuronides should not be 
problematic also in the negative ionization mode due to the presence of the acidic carboxylic 
group on glucuronic moiety with the reported pKa of around 3 (Farrell, Poquet et al. 2011). 
However, the negative ionization is often less sensitive than the positive one. Furthermore, 
fragmentation mechanisms in negative ion mode are frequently hard to predict and 
understand. Moreover, in negative ionization the specificity may be worse than in the 
positive mode (Pruvost, Théodoro et al. 2008). On many occasions, it is therefore advisable 
to try to develop a method for glucuronide quantification using the positive ionization 
mode, especially if the aglycone is a proton-acceptor (a weak base).  In positive-ion mode, an 
abundant fragment [M + H − 176]+ is detected in most cases after a glucuronide 
fragmentation; the neutral loss of 176 Da corresponds to a monodehydrated glucuronic acid. 
Acyl- or benzyl glucuronides, however, may undergo a loss of 194 Da (glucuronic acid) 
from the pseudo- or quasi-molecular ions, either in addition to the loss of 176 Da or even 
exclusively (Levsen, Schiebel et al. 2005). 
Sometimes however, the positive ionization mode cannot be used if the aglycone is not a 
base or does not accept a proton or any other positive adduct-forming ions, like for example 
Na+, K+, NH4+ etc. In such cases, it is necessary to use the negative ionization or switch to 
another type of ionization. If analyte derivatization has been employed to increase the 
ionization efficiency like for example with steroids or with paracetamol glucuronide (Ohta, 
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Kawakami et al. 2003), then the negative ionization mode may be even superior in 
sensitivity to the positive mode because the noise in negative mode may be lower, thereby 
increasing the signal/noise ratio (Higashi and Shimada 2004). 
Atmospheric pressure chemical ionization (APCI) interface may sometimes be beneficial 
over the ESI if the principally lower sensitivity of APCI is still adequate for the intended 
study. The APCI may be less prone to matrix effects due to plasma components and salts 
(Schwartz, Desai et al. 2006), especially if isotope labeled internal standard for glucuronide 
is not available (Matuszewski, Constanzer et al. 1998; Matuszewski, Constanzer et al. 2003). 
Furthermore, APCI seems to have a wider dynamic response range than ESI (Ramanathan, 
Comezoglu et al. 2009). 
Novel LC-MS interfaces include APPI (atmospheric photo ionization, which is similar to 
APCI and may be important for less polar analytes;  further, nanospray ionization (NSI) 
coupled with nano flow LC may provide a superior limit of quantification and reduced 
matrix effects (Ramanathan, Comezoglu et al. 2009) 
5.2 Mass spectrometry operation modes for glucuronide detection 
Tandem MS is the key principle for metabolite structure elucidation and quantification  
(Clarke, Rindgen et al. 2001). There are many layouts and types of mass filters or analyzers 
for selecting the parent and daughter ions and the collision cells. For example just to name a 
few major types of mass analyzers: quadrupole/linear ion trap, triple stage quadrupole 
(QQQ), time of flight (TOF), hybrid instruments (QTOF, QTRAP) and others. For detection 
and quantification of glucuronides in complex biological matrices, the triple quadrupole 
mass spectrometer is usually the instrument of choice due to the high selectivity and 
superior sensitivity (Mullangi, Bhamidipati et al. 2005). Therefore, our brief review will 
focus on mass experiments performed typically in a QQQ type of instrument. 
Precursor ion scan mode is usually used at the start of conjugate identification; aglycone is 
selected as the product by Q3 mass filter and Q1 is scanning for the possible conjugates that 
may give rise to the selected parent fragment after a collision induced dissociation (CID). 
Such an experiment may reveal for example glucuronides, glucosides, sulfates and 
glutathione conjugates with mass shifts of m/z  176, 80, 162, 305 Da, respectively (Levsen, 
Schiebel et al. 2005; Ramanathan, Comezoglu et al. 2009). 
Constant neutral-loss experiment is the most suitable mode experiment for searching the 
selected or expected conjugates in a sample as it detects the loss of a neutral fragment. Here, 
both Q1 and Q3 are scanning at the same time, with a pre-selected mass shift between them. 
Therefore, the analyst does not need to know the exact mass of the conjugate or its parent (it 
may undergo an unknown phase I metabolic conversion prior to the conjugation). The result 
of such an experiment is the m/z of the parent molecule before the CID and the resulting 
mass shift of 176 Da (for glucuronic acid), similar to the precursor ion scan experiment, 
described in the upper paragraph. In neutral loss experiment and in positive ionization 
mode, the glucuronides will produce a nominal shift of m/z 176 (176.0321 on accurate mass 
analyzers) (Ramanathan, Comezoglu et al. 2009). In negative ionization, the glucuronides 
produce ions at m/z 175 (anhydrous glucuronic acid) and 113 (a fragment of glucuronic acid) 
(Fay 2010). 
Product ion scan experiment is performed on a single pre-selected ion in Q1, which is 
fragmented in the collision cell and daughter ions are scanned by Q3. The result of such an 
experiment is a full scan product ion spectrum, which may also contain unfragmented 
parent ion (figure 1). 
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Fig. 1. A product ion scan from raloxifene-6-glucuronide (m/z 650.1), aglycone fragment (m/z 
474.4), phenyl benzotiophene ring (m/z 268.7) and N-ethyl-piperidine fragment (m/z 112) 
(Trontelj, Bogataj et al. 2007). With permission. 
Usually, the full scan mode does not provide sufficient sensitivity in a triple quadrupole MS 
for a proper glucuronide detection or quantification in a complex matrix (Fay 2010). 
The Selected Reaction Monitoring (SRM) and the Multiple Reaction Monitoring (MRM) 
modes are the techniques of choice for selective and sensitive glucuronide quantification. 
Here the Q1 and Q3 are set at the selected m/z values for conjugate (glucuronide) and its 
parent molecule, respectively. Additional specificity for isobaric ions in MS detector can be 
provided by the high-field asymmetric waveform ion mobility spectrometry (FAIMS) 
module, which is inserted between the ion source and the high vacuum MS inlet. The 
principle of this additional separation technique is that the ion mobility at high electric fields 
can differ according to the shape of the ions. Therefore, FAIMS can separate isomeric or 
isobaric analytes that the LC and ordinary MS cannot (Hatsis and Kapron 2008).  On a 
model acyl-glucuronide of ifetroban Xia et al. have demonstrated the use of FAIMS for 
locating the place where the acyl glucuronide is being fragmented to its parent inside the 
mass spectrometer (Xia and Jemal 2009). FAIMS method is also one of the confirmatory 
methods for detection of testosterone glucuronide in urine after a hydrolysis and  immuno-
affinity separation coupled to LC-MS/MS (Fong-Ha and et al. 2010). Guddat et al. reported 
a better interference removal with FAIMS in an anti-doping testing of human urine, which 
should effectively extend the post-dose detection time of androgen steroids and their 
glucuronides (Guddat, Thevis et al. 2009). 
5.3 Other mass spectrometry approaches used in glucuronide characterization 
The described mass experiments in previous subparagraph can be performed also on some 
other tandem instruments as well, like for example on ion traps, where the CID happens in 
time rather than in space, as in triple quads. The sensitivity of ion traps is usually lower 
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compared to QQQ instruments, however, they tend to be cheaper. Furthermore, with ion 
traps, MSn experiments can be performed for possible structure elucidation.  
QTRAP, which is a hybrid between a triple quad and an ion trap, can perform all the 
described tandem mass experiments and more – there is the possibility to perform MSn 
experiments (multiple stages of fragmentation) which may be beneficial for glucuronide 
structure elucidation, but lacks the mass accuracy of a Q-TOF. Information dependent 
acquisition (IDA) can trigger the product ion scans (MS2 and MS3) when a certain ion 
intensity threshold is reached in full scan or neutral loss scan experiment. Therefore, IDA 
should shorten the cycle time and provide some structural information in a minimal number 
of analytical runs. 
The mass spectrometers that enable accurate mass measurements in LC/MS are time-of-
flight instruments and their hybrids (TOF), Q-TOF, TOF-TOF and Orbitrap or Fourier 
transform ion cyclotron resonance mass spectrometers (FTICRMS) (Tolonen, Turpeinen et 
al. 2009). It is noteworthy that an accurate mass instrument like Orbitrap can be used for 
quantification and glucuronide detection comparable to a middle range QQQ because of the 
Orbitrap’s extreme selectivity due to its high resolution of 15000 and more (mass/FWHM)  
(Zhang, Yu et al. 2009).  
Q-TOF instruments are also capable of tandem mass experiments. These hybrid systems 
offer an increased mass accuracy and mass resolution of TOF and provide a good 
fragmentation capability. Furthermore, full scan mode in TOF mass analyzers provides an 
increased sensitivity compared to a QQQ. Therefore, the product ion scan experiment on Q-
TOF offers significant benefits in terms of accuracy and sensitivity, which may help in 
element and structural elucidation for isomeric glucuronides, like for example multiple 
estriol glucuronides (Lampinen-Salomonsson, Bondesson et al. 2006). On the other hand, 
precursor ion scan and neutral loss experiments cannot be performed on a Q-TOF 
(Hoffmann and Stroobant 2007). 
A good example of complimentary approach by different mass spectrometers (QQQ, ion 
trap, Q-TOF) is presented on a complicated mixture of estriol glucuronide isomers and their 
structure elucidation (Lampinen-Salomonsson, Bondesson et al. 2006). 
5.4 Data acquisition and ion channel cross-talk 
For glucuronide quantification, the ion source settings are important for efficient ionization. 
However, the parameters of quadrupoles and detector in MRM mode are also important for 
LC-MS selectivity and especially, sensitivity. If analyte concentration level and sensitivity of 
the instrument permit it, the mass resolution of both Q1 and Q3 should be set to at least one 
unit (0,7-1.0) Da full width at half maximum (FWHM)). If the concentration level of 
glucuronides is very low, then increasing the mass window of both quadrupoles to up to 3 
units may increase the signal intensity up to 10 times and more (author’s own experience) 
without the equal increase in noise at the high m/z values as can be expected for glucuronide 
conjugates. However, the selectivity of the method may suffer. Nowadays, triple 
quadrupoles with enhanced resolution exist which offer a resolution of ≤0.1 FWHM and 
may provide a significant increase in selectivity from the interfering substances (like PPG, 
PEG) and a minimal loss in sensitivity (3 times lower signals, but lower noise as well) (Yang, 
Amad et al. 2002).  
Another important parameter is the dwell time (the time at which quadrupole stays at one 
m/z value). The greater the dwell time, the better is the sensitivity and the slower rate of data 
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Fig. 2. MRM chromatogram of an extracted urine sample containing raloxifene di-
glucuronide (trace A), two isobaric raloxifene monoglucuronides (trace B), parent raloxifene 
(trace C) and haloperidol (D) as an internal standard. Ion channel cross-talk is evident in 
traces B in C, where the little peaks in front of analytes (marked as stars *) present cross talk 
and originate from different analytes (producing the same daughter ion fragments).  
acquisition. With shorter dwell times, the probability of ion-channel cross talk also increases. 
Ion-channel cross talk is a false positive signal in a SRM channel that originates from 
another analyte. A typical example is the signal of aglycone in the SRM trace of its conjugate 
(Figure 2, trace C with two peaks originating from cross-talk).  Typical values of dwell times 
are 1 to 250 ms (Lee, Zhu et al. 2011). However, with modern UHPLC columns which can 
produce very high and narrow peaks (often less than 5 s wide at half height) (Jemal, Ouyang 
et al. 2010), the data acquisition rate should be fast enough to provide at least 10-15 points 
per peak. Not only the dwell time, also the cycle time (the summation of dwell times of all 
MRMs and pause times between them) is extremely important for data acquisition rate. 
Therefore, for the fastest cycle times with long-enough dwell times it is advisable to use the 
scheduled MRM mode if ultimate sensitivity is required. Again, an effective and robust 
chromatographic separation of analytes is vital. In glucuronide analysis, ion channel cross-
talk is often observed even with high-end QQQ instruments where the commercial 
A 
B 
Raloxifene di-glucuronide: m/z 474 + 2*176 
Raloxifene monoglucuronides: 
m/z 474+176
Raloxifene parent: m/z 474112 
Internal standard 
(haloperidol) 
C 
D 
*
* *
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brochures claim that there is no cross talk even at 1 ms dwell time (author’s own experience, 
see figure 2). This however is of no real concern if the analytes are baseline separated 
chromatographically.  
The detector voltage (or delta EMV as it is sometimes called) has also a big influence on the 
signal intensity. However, with increasing the detector voltage, the rise in background noise 
is almost certain as well. Furthermore, the dynamic range of the detector may be narrower 
with higher voltage and the lifetime of detector may be shortened by using high voltages 
over longer periods of time.  
5.5 Matrix effects 
The most problematic matrix components for LC-MS/MS analyses are supposed to be the 
phospholipids, which are rather lipophilic and therefore, late-eluting (Chambers, 
Wagrowski-Diehl et al. 2007). The glucuronides on the other hand, are usually more 
hydrophilic and fast eluting. Yet, they may still be very susceptible to interferences from the 
co-eluting matrix components (author’s own in-house experiences, data not shown). Not 
only the phospholipids, but also earlier eluting lysophospholipids can cause substantial 
matrix effects (Xia and Jemal 2009), which may interfere with the quantification of drugs 
and their metabolites (Jemal, Ouyang et al. 2010).  Especially difficult matrices are plasma 
and urine, where even after a LLE or SPE clean-up, major matrix effects can be observed.  
Recovery (RE) and matrix effect (ME) can be calculated from extraction experiments of 
blank matrix which is pre- and post- spiked by using equations 1 and 2 (Matuszewski, 
Constanzer et al. 2003), see also paragraph 3.2. 
 
2Eq.%100*
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spiked-post
1
1Eq.%100*
spiked-post
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


 

ME
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A similar method for calculation of the matrix effect and recovery can also be used with 
other types of extraction and protein precipitation. Note that the presented method implies 
the calculation of absolute matrix effect. However, much more important for bioanalytical 
quantification is the relative matrix effect, caused by interindividual variability in the sample 
matrix (Matuszewski, Constanzer et al. 2003). Therefore, at least 5 matrices from individual 
donors have to be used to asses the relative matrix effect either by a post spike method 
presented above or by comparing the slopes of calibration lines in those matrices. The 
coefficient of variation of slopes should not exceed 4-5% (Matuszewski, Constanzer et al. 
2003). The use of an isotope labeled aglycone as an internal standard does not necessarily 
correct the matrix effect for glucuronide as well, because the retention times between both 
analytes are supposed to be different and the nature and/or concentration of the co-eluting 
matrix components are very likely different as well (Taylor 2005). Therefore, to thoroughly 
compensate the matrix effects for glucuronides, their labeled analogues should be used. 
Even with labeled internal standards, the analyst should be cautious, since the purity of a 
labeled standard may not be 100% and studies should be performed to confirm the isotope 
integrity of the label in a sample matrix and during the sample handling. Furthermore, the 
possible presence of an ion channel cross-talk between the analyte and the labeled standard 
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SRMs must be investigated as same fragments can be formed from the analyte and the 
internal standard (Chavez-Eng, Constanzer et al. 2002; Matuszewski, Constanzer et al. 2003). 
Alternatively, the -glucuronidase approach (paragraph 3.1) can be used to transform the 
glucuronide into its parent molecule, for which an isotope labeled analogue may be 
available. If more than one glucuronide isomers are present in a sample then the -
glucuronidase approach cannot be used directly to quantify each of the present 
glucuronides. In such cases, the response factors for each glucuronide has to be determined 
based on isolated -glucuronidase incubations for each isolated glucuronide. The matrix 
effects in such cases cannot be overcome with a simple use of the labeled analogue of the 
parent aglycone, because the quantification of glucuronides has to be performed directly 
with their MRMs and not via their degradation to parent aglycone.  
6. Some selected examples 
In this section, a brief overview of the current literature is given, regarding the use of a LC-
tandem-MS instrument for the quantification of glucuronides in various samples from both 
in vitro and in vivo studies, such as microsome and tissue incubations and pharmacokinetic 
studies or forensic applications (Tables 1, 2). 
 
 
 
 
 
Analyte Matrix Sample preparation separation 
technique
Ionization / 
type of MS 
Range Reference 
Nicotine-N 
glucuronideD  
microsome 
incubation 
PP with perchloric acid  (+) ESI / 
QQQ 
10-1000 
nM 
(Guo, Zhou et 
al. 2011) 
ethyl-
glucuronide 
human hair water extraction 
followed by SPE on 
activated carbon 
UHPLC (-) ESI 
QQQ 
2pg/g – 
300 pg/g 
hair 
(Kronstrand, 
Brinkhagen et 
al. 2011) 
raloxifene O- 
glucuronides 
human urine RP polymeric SPE UHPLC 
C18 
(+)ESI / 
QQQ 
1 -4800 
nM* 
(Trdan, Roskar 
et al. 2011) 
morphine-O-
glucuronides 
human urine RP (C18) SPE HPLC- 
HILIC 
(+)ESI / 
TOF 
50-5000 
µg/L 
(Kolmonen, 
Leinonen et al. 
2010) 
sorafenib-O-
glucuronideD 
mouse plasma 
and liver 
homogenate 
PP HPLC C18 (+)ESI / 
QQQ 
1-500 
µg/L 
(Sparidans, 
Vlaming et al. 
2009) 
rampiril-acyl-
glucuronide 
plasma RP (C18) SPE HPLC C18 (+)ESI / 
QQQ 
1-500 
µg/L 
(Tan, Jin et al. 
2009) 
cediranib-N+ -
glucuronideD 
micorosomes/ 
feces 
PP / SPE HPLC 
C18 
(+)ESI /  
ion trap 
? (Lenz, Spear et 
al. 2010) 
THC-acyl-
glucuronide 
blood, liver, 
muscle, urine, 
bile 
ACN homogenization 
/LLE with 
ethylacetate/hexane 
HPLC 
C18 
(+)ESI 100-1000 
µg/L 
(Gronewold 
and Skopp 
2011) 
D signifies the use of a labeled internal standard for glucuronide  
* The range was divided into two calibration curves 
 
 
Table 1. Some selected recent examples of a direct glucuronide measurement approach. For 
descriptions of abbreviations, please see the text. 
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Analyte Matrix Sample 
preparation 
separation 
technique 
Ionization / 
type of MS
Range Reference 
SN-38-O-
glucuronide 
plasma PP / -
glucuronid. 
HPLC (+) ESI 
QTRAP 
0.5-200 µg/L (Zhang, Dutschman et 
al. 2009) 
ezetimibe-O-
glucuronide 
feces LLE / tert 
butyl ether 
HPLC C18 (-) APCI 
/QQQ 
0.1-20 mg/L 
for total 
ezetimibe 
(Oswald, Scheuch et al. 
2006) 
quercetine-O-
glucuronide 
rat brain 
tissue 
 -glucuronid. 
/ LLE (ethyl 
acetate) 
HPLC 
C18 
(-) ESI / 
QQQ 
? (Ishisaka, Ichikawa et 
al. 2011) 
bisphenol A- O-
glucuronide 
human 
urine 
 -glucuronid. 
/ PP / On-line 
SPE 
HPLC C18 (-) APCI / 
QTRAP 
1-500 pg/µL (Völkel, Kiranoglu et al. 
2008) 
Table 2. Some selected recent examples of an indirect glucuronide measurements (by 
deconjugation). For descriptions of abbreviations, please see the text. 
7. Summary 
The glucuronide metabolites are important both for toxicology and for pharmacokinetics of 
many drugs and xenobiotics. Even though glucuronides often lack the pharmacological 
activity, after de-conjugation, the free aglycone can regain that activity and may present an 
environmental burden. Furthermore, glucuronides may be used as markers of the past 
substance exposure, like for example the ethyl-glucuronide in body hair for alcohol abuse or 
the cannabinoid-glucuronides for cannabis abuse. Therefore, quantification of glucuronide 
metabolites in biological matrices may be very important. However, due to their highly 
hydrophilic nature, the separation of glucuronides from the matrix (body fluids, hair, and 
environmental samples) may be difficult. For that purpose, many sample preparation 
techniques can be used, including the liquid extraction, solid phase extraction, dried blood 
spots, protein precipitation, direct injection, on-line solid phase extraction and others. 
Furthermore, some glucuronides, such as acyl- and N-glucuronides can be highly unstable. 
Glucuronides can be measured either by a direct or an indirect approach. With the latter, the 
glucuronides are cleaved back to their parent aglycone by enzymes known as the -
glucuronidases, afterwards the freed aglycone is quantified according to its calibration 
curve.  With direct measurement, unchanged glucuronides are quantified by their MRMs, 
where some significant benefits can be expected, namely, quicker sample preparation, better 
accuracy and precision, and selectivity towards glucuronide isomers. Tandem mass 
spectrometry is the corner stone for direct glucuronide quantification because it offers both 
exceptional selectivity and sensitivity. However, this approach requires the use of authentic 
glucuronide standards. This necessity can be avoided with the semi-quantitative approach, 
where the response factor for glucuronide is used to quantify it against the calibration curve 
for the parent. The recent advancement of mass spectrometers’ speed and sensitivity 
coupled with higher mass accuracy promises an even easier measurement of glucuronides 
in complex biological matrices, allowing a faster method development, robust response, and 
quicker sample preparation. Notwithstanding the described improvements, the glucuronide 
identification and quantification in difficult matrices will still remain a challenge for the 
analyst.    
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